• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用机器学习为膀胱癌患者建立术前淋巴结转移模型。

Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma.

机构信息

Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

BMC Cancer. 2024 Jun 13;24(1):725. doi: 10.1186/s12885-024-12467-4.

DOI:10.1186/s12885-024-12467-4
PMID:38872141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11170799/
Abstract

BACKGROUND

Lymph node metastasis (LNM) is associated with worse prognosis in bladder urothelial carcinoma (BUC) patients. This study aimed to develop and validate machine learning (ML) models to preoperatively predict LNM in BUC patients treated with radical cystectomy (RC).

METHODS

We retrospectively collected demographic, pathological, imaging, and laboratory information of BUC patients who underwent RC and bilateral lymphadenectomy in our institution. Patients were randomly categorized into training set and testing set. Five ML algorithms were utilized to establish prediction models. The performance of each model was assessed by the area under the receiver operating characteristic curve (AUC) and accuracy. Finally, we calculated the corresponding variable coefficients based on the optimal model to reveal the contribution of each variable to LNM.

RESULTS

A total of 524 and 131 BUC patients were finally enrolled into training set and testing set, respectively. We identified that the support vector machine (SVM) model had the best prediction ability with an AUC of 0.934 (95% confidence interval [CI]: 0.903-0.964) and accuracy of 0.916 in the training set, and an AUC of 0.855 (95%CI: 0.777-0.933) and accuracy of 0.809 in the testing set. The SVM model contained 14 predictors, and positive lymph node in imaging contributed the most to the prediction of LNM in BUC patients.

CONCLUSIONS

We developed and validated the ML models to preoperatively predict LNM in BUC patients treated with RC, and identified that the SVM model with 14 variables had the best performance and high levels of clinical applicability.

摘要

背景

淋巴结转移(LNM)与接受根治性膀胱切除术(RC)治疗的膀胱癌患者的预后较差相关。本研究旨在开发和验证机器学习(ML)模型,以预测接受 RC 和双侧淋巴结清扫术的膀胱癌患者的 LNM。

方法

我们回顾性收集了在我院接受 RC 和双侧淋巴结清扫术的膀胱癌患者的人口统计学、病理学、影像学和实验室信息。患者被随机分为训练集和测试集。使用五种 ML 算法建立预测模型。通过接受者操作特征曲线下面积(AUC)和准确性评估每个模型的性能。最后,我们根据最优模型计算了每个变量的相应系数,以揭示每个变量对 LNM 的贡献。

结果

共有 524 例和 131 例膀胱癌患者最终分别纳入训练集和测试集。我们发现支持向量机(SVM)模型具有最佳的预测能力,在训练集中 AUC 为 0.934(95%置信区间[CI]:0.903-0.964),准确率为 0.916,在测试集中 AUC 为 0.855(95%CI:0.777-0.933),准确率为 0.809。SVM 模型包含 14 个预测因子,影像学中阳性淋巴结对膀胱癌患者 LNM 预测的贡献最大。

结论

我们开发并验证了 ML 模型,以预测接受 RC 治疗的膀胱癌患者的 LNM,并确定了包含 14 个变量的 SVM 模型具有最佳性能和高水平的临床适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/e583e69c38c7/12885_2024_12467_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/8fe70edd7dbd/12885_2024_12467_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/fe0ad7514509/12885_2024_12467_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/25559d5c6420/12885_2024_12467_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/e583e69c38c7/12885_2024_12467_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/8fe70edd7dbd/12885_2024_12467_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/fe0ad7514509/12885_2024_12467_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/25559d5c6420/12885_2024_12467_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/11170799/e583e69c38c7/12885_2024_12467_Fig4_HTML.jpg

相似文献

1
Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma.运用机器学习为膀胱癌患者建立术前淋巴结转移模型。
BMC Cancer. 2024 Jun 13;24(1):725. doi: 10.1186/s12885-024-12467-4.
2
Development and validation of a preoperative nomogram to predict lymph node metastasis in patients with bladder urothelial carcinoma.开发和验证一种术前列线图,以预测膀胱尿路上皮癌患者的淋巴结转移。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10911-10923. doi: 10.1007/s00432-023-04978-7. Epub 2023 Jun 15.
3
Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.膀胱癌的临床淋巴结病:接受根治性膀胱切除术而未接受新辅助化疗的患者的横断面成像表现和肿瘤学结局的跨大西洋合作。
Eur Urol Focus. 2018 Mar;4(2):245-251. doi: 10.1016/j.euf.2016.11.005. Epub 2016 Nov 23.
4
Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.结外侵犯是膀胱癌伴淋巴结转移患者的一个强有力的预后因素。
Eur Urol. 2013 Nov;64(5):837-45. doi: 10.1016/j.eururo.2012.07.026. Epub 2012 Jul 20.
5
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.膀胱癌患者根治性膀胱切除术前预测需要扩大淋巴结清扫术的需求。
Eur Urol Focus. 2021 Sep;7(5):1067-1074. doi: 10.1016/j.euf.2020.09.009. Epub 2020 Oct 2.
6
Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.在接受根治性膀胱切除术的非肌肉浸润性膀胱癌患者中,预测淋巴结清扫充分的因素及其对生存的影响。
Urol Oncol. 2020 Oct;38(10):796.e7-796.e14. doi: 10.1016/j.urolonc.2020.04.027. Epub 2020 May 20.
7
Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis.腹腔镜单孔根治性膀胱切除术与传统腹腔镜根治性膀胱切除术治疗膀胱尿路上皮癌患者的配对病例对照分析
J Endourol. 2017 Dec;31(12):1259-1268. doi: 10.1089/end.2017.0525.
8
Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.基于术前计算机断层扫描原发性肿瘤分期(T 分期)的腹腔镜下盆腔淋巴结清扫系统在膀胱癌中的应用:单中心前瞻性研究结果。
BJU Int. 2013 Jul;112(2):E87-91. doi: 10.1111/j.1464-410X.2012.11650.x. Epub 2013 Jan 16.
9
Effect of delayed radical cystectomy for invasive bladder tumors on lymph node positivity, cancer-specific survival and total survival.浸润性膀胱肿瘤延迟根治性膀胱切除术对淋巴结阳性率、癌症特异性生存率和总生存率的影响。
Tumori. 2018 Dec;104(6):434-437. doi: 10.5301/tj.5000626. Epub 2018 May 8.
10
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.

引用本文的文献

1
Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.基于基因表达的膀胱癌淋巴结转移预测指标评估。
Bladder Cancer. 2025 Aug 21;11(3):23523735251370895. doi: 10.1177/23523735251370895. eCollection 2025 Jul-Sep.
2
Hot Spots in Urogenital Basic Cancer Research and Clinics.泌尿生殖系统基础癌症研究与临床热点
Cancers (Basel). 2025 Mar 31;17(7):1173. doi: 10.3390/cancers17071173.
3
An efficient graph attention framework enhances bladder cancer prediction.一种高效的图注意力框架增强了膀胱癌预测。

本文引用的文献

1
Development and validation of a preoperative nomogram to predict lymph node metastasis in patients with bladder urothelial carcinoma.开发和验证一种术前列线图,以预测膀胱尿路上皮癌患者的淋巴结转移。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10911-10923. doi: 10.1007/s00432-023-04978-7. Epub 2023 Jun 15.
2
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.开发和外部验证用于预测前列腺癌患者淋巴结转移的机器学习模型。
Eur Urol Oncol. 2023 Oct;6(5):501-507. doi: 10.1016/j.euo.2023.02.006. Epub 2023 Mar 1.
3
Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Sci Rep. 2025 Apr 1;15(1):11127. doi: 10.1038/s41598-025-93059-5.
基于淋巴结转移指标的膀胱癌患者预后列线图:一项 SEER 人群研究和外部验证。
Cancer Med. 2023 Mar;12(6):6853-6866. doi: 10.1002/cam4.5475. Epub 2022 Dec 7.
4
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.机器学习模型在预测非转移性肾细胞癌手术后复发中的应用。
Eur Urol Oncol. 2023 Jun;6(3):323-330. doi: 10.1016/j.euo.2022.07.007. Epub 2022 Aug 18.
5
A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma.一种用于预测和评估肾细胞癌患者淋巴转移的新型列线图
Front Oncol. 2022 Apr 11;12:851552. doi: 10.3389/fonc.2022.851552. eCollection 2022.
6
Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.根据不同淋巴结位置评估膀胱癌术前淋巴结分期的诊断准确性:来自欧洲泌尿外科学会-青年泌尿外科医生的多中心队列研究。
Urol Oncol. 2022 May;40(5):195.e27-195.e35. doi: 10.1016/j.urolonc.2022.01.002. Epub 2022 Feb 27.
7
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).欧洲泌尿外科学会非肌层浸润性膀胱癌(Ta、T1和原位癌)指南
Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10.
8
Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer.膀胱癌淋巴结转移的预测列线图及危险因素
Front Oncol. 2021 Jun 16;11:690324. doi: 10.3389/fonc.2021.690324. eCollection 2021.
9
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers.泌尿生殖系统病理学学会关于变体组织学、T1 分期、分子分类学以及免疫治疗和 PD-L1 检测对尿路上皮癌的影响的更新。
Adv Anat Pathol. 2021 Jul 1;28(4):196-208. doi: 10.1097/PAP.0000000000000309.
10
Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer.临床病理特征识别与深度可迁移图像特征表示的融合提高了前列腺癌淋巴结转移预测的准确性。
EBioMedicine. 2021 Jun;68:103395. doi: 10.1016/j.ebiom.2021.103395. Epub 2021 May 25.